AboutContact us
dotsbydots
SEARCHCONTACT US

Buzz

Most popular

Daily
Weekly
1
Cisco acquires AI security startup Astrix for $400 million
2
Five bidders advance in Nice’s $2.5 billion Actimize sale process
3
The 50 most promising Israeli startups - 2026
4
Israeli tech veterans launch $100 million AI and cyber fund
5
Israeli startup bets on psychedelic mushrooms for mental health treatment
More news

Stock

6 stories about Stock
ד"ר אמיר ולדמן מייסדי הום סקינוביישנס מעורב בפרשת מובילאיי

Emails in Mobileye Insider Trading Case Pinpoint Leak’s Source

18.12.17|Tomer Ganon and Ran Abramson
The documents show how defendants communicated information about the stock’s expected spike
ד"ר אמיר ולדמן מייסדי הום סקינוביישנס מעורב בפרשת מובילאיי

Israeli Defendant Denies Mobileye Insider Trading Charges

08.12.17|Tomer Ganon and Ran Abramson
Amir Waldman, former vice president of Israel-based medical device company Syneron Medical, is being accused by the SEC of making over $4 million from insider trading in Mobileye securities
default image

Allergan to Sell Teva Shares to J.P. Morgan

14.11.17|Dror Reich and Lilach Baumer
Allergan announced it pledged its 9.8% stake in Teva to J.P. Morgan as collateral, as part of a loan agreement. The company already agreed to sell a quarter of the stock in the first quarter of 2018
אננס אננסים

MediWound Loses Stock Purchase Agreement Case

14.11.17|Dror Reich
The burn and wound treatment company was ordered to follow through on previous agreement to buy shares of biotech company Polyheal
מטה טבע פתח תקווה

Allergan Planning Sale of its Teva Stock

01.11.17|Dror Reich and Lilach Baumer
For the third quarter of 2017, Allergan reported an operating loss of $4.02 billion, $1.3 billion of which is due to the depreciation of its Teva securities.
מטה טבע פתח תקווה

Teva Offloads Holdings in Australia’s Mesoblast

25.10.17|Dror Reich and Lilach Baumer
The stem-cell therapy company diluted Teva’s shares through a new offering in August
Previous Articles